Design, synthesis and structure-activity relationship of novel pyrazolo[3,4-d]pyrimidine-chalcone hybrids as broad-spectrum antimicrobial agents: mechanistic insights from molecular docking, molecular dynamics and DFT studies
Authors: Pandya, Tejas H; Patel, Kishan M; Solanki, Priyanka A; Abubakar, Siddique; Divetia, Darshan H; Akbari, Vikunjana K
Source journal: Bioorganic chemistry (2026-11-09)
DOI: 10.1016/j.bioorg.2026.110754
Abstract
The emergence of antibiotic resistance necessitates the development of structurally diverse therapeutic agents. In this work, a series of novel pyrazolo[3,4-d]pyrimidine-chalcone hybrids 7(a-j) was designed and synthesized through a multi-step sequence involving Claisen-Schmidt condensation. All compounds were fully characterized by (1)H NMR, (13)C NMR, and mass spectrometry. The synthesized hybrids were evaluated for in vitro antimicrobial activity using standardized broth microdilution assays (CLSI guidelines) against a panel of standard ATCC/MTCC Gram-positive, Gram-negative, and fungal pathogens. Quantitative minimum inhibitory concentration (MIC) determinations demonstrated derivative-dependent activity profiles: the 4-cyano derivative 7 g exhibited prominent antibacterial potency against Bacillus subtilis MTCC 442 (MIC = 12.5 mug/mL; 28.2 muM) and Staphylococcus aureus MTCC 96 (MIC = 25 mug/mL; 56.5 muM), while the 3-trifluoromethyl analogue 7i showed marked activity against Pseudomonas aeruginosa MTCC 1688 (MIC = 12.5 mug/mL; 25.7 muM). In antifungal assays, the unsubstituted counterpart 7j demonstrated notable dual-strain antifungal activity against Candida albicans MTCC 227 and Aspergillus niger MTCC 282 (MIC = 50 mug/mL; 119.8 muM), while the 4-nitro derivative 7f showed inhibitory activity against C. albicans (MIC = 62.5 mug/mL; 135.2 muM). Molecular docking against bacterial DNA gyrase B (PDB ID: 1KZN), S. aureus dihydrofolate reductase (DHFR, PDB ID: 3SRW), and fungal lanosterol 14alpha-demethylase (CYP51, PDB ID: 5V5Z) provided structural and binding mode hypotheses supporting the observed whole-cell bioactivities. Density functional theory (DFT) calculations at the B3LYP/6-31G(d,p) level described frontier molecular orbital distributions and global reactivity indices, elucidating substituent-dependent electronic properties. A 100 ns molecular dynamics (MD) simulation and MM-GBSA binding free energy analysis (DeltaGbind = -64.8 +/- 5.0 kcal/mol) of the CYP51-7f complex demonstrated local active-site conformational stability. In vitro cytotoxicity assays in human embryonic kidney (HEK-293) cells confirmed low cytotoxicity and favorable selectivity indices. Overall, this integrated experimental and computational study highlights pyrazolo[3,4-d]pyrimidine-chalcone hybrids as promising lead scaffolds requiring further structural optimization and target-specific biological validation.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.